CONTENTS
Quick Answer:
A GLP-1 weight loss injection uses a class of prescription medicines called GLP-1 receptor agonists, which may support weight loss by helping regulate appetite and slow digestion. In Singapore, they are available only through a doctor’s prescription after clinical assessment confirms they are appropriate, and they are generally used alongside lifestyle changes such as diet and exercise, not as a first step or a stand-alone solution. Suitability varies from person to person.
If you have been trying to lose weight in Singapore for a while, smaller hawker portions, more walks to the MRT instead of a Grab ride, skipping supper, you already know it is not always simply a matter of willpower. For some people, a bit more consistency really is the missing piece.
For others, something in the body’s own appetite and metabolism signalling is working against them no matter how disciplined they are, and this is where the GLP-1 weight loss injection enters the conversation. These medicines, the ones behind much of the recent buzz, are not a first step, and they are not for everyone. Whether one is relevant to you starts with an honest conversation with a doctor, not a decision made alone at home.
Singapore’s own health data shows why this conversation matters. According to the Ministry of Health’s National Population Health Survey 2024, the proportion of adults with obesity rose from 10.5% in 2019 to 2020 to 12.7% in 2023 to 2024, while about 22.8% now fall into the higher-risk overweight category. Behind these numbers are people with very different reasons for carrying excess weight, from lifestyle patterns to underlying hormonal conditions, which is exactly why a proper diagnosis should come before any medication, including a GLP-1 injection, is considered.
This guide explains what GLP-1 injections are, how they work, who a doctor might consider them for, and what the diagnostic and treatment process looks like at a GP clinic in Singapore.
Understanding Why Weight Management Is Not One-Size-Fits-All
Body weight is regulated by a mix of behavioural and biological factors, and this is one reason why willpower alone does not always explain weight outcomes. Appetite, hunger, and how full a person feels after a meal are influenced by a network of gut hormones and brain signals, and this system does not behave identically in everyone. Some people gain weight primarily through lifestyle patterns such as irregular meal timing, high calorie intake, and low physical activity typical of Singapore’s fast-paced, desk-bound work culture. Others have an underlying metabolic or hormonal driver, such as insulin resistance, polycystic ovary syndrome (PCOS), or thyroid dysfunction, one of the many possible causes and complications of obesity, that makes weight loss disproportionately difficult even with consistent effort.
This is the context in which GLP-1 injections are discussed. They target one part of the appetite-regulation system, and a doctor’s role is to work out, through assessment, whether that particular mechanism is likely to be relevant to a given patient’s weight gain, or whether other factors need to be addressed first.
What Is a GLP-1 Receptor Agonist?
GLP-1, or glucagon-like peptide-1, is a hormone naturally produced in the gut after eating. It plays a role in stimulating insulin release, slowing down how quickly the stomach empties, and signalling to the brain that the body has had enough food. A GLP-1 injection belongs to a class of prescription medicines called GLP-1 receptor agonists. These medicines mimic the action of the natural GLP-1 hormone and are commonly given as a weekly or daily injection.
This class of medicine was originally developed for type 2 diabetes management, where its effect on insulin and blood sugar control was the primary benefit. Over time, clinical research found that certain GLP-1 injections, when used at approved doses for weight management, also produced meaningful weight reduction by helping people feel fuller for longer and reducing overall food intake. This is why medicines in this class are now used for both blood sugar control and, in specific circumstances, weight management, although not every GLP-1 injection is approved or prescribed for both purposes.
As with any prescription-only medicine in Singapore, GLP-1 injections cannot legally be advertised or offered for sale directly to the public. They may only be prescribed following a consultation, clinical assessment, and diagnosis by a doctor, in line with Health Sciences Authority (HSA) regulations governing prescription-only medicines.
How GLP-1 Injection May Support Weight Loss
The weight loss effect of these medicines comes mainly from appetite suppression and delayed gastric emptying, which together tend to reduce how much a person eats without the same degree of conscious food restriction. The clinical evidence for this is well documented. The STEP 1 trial, published in the New England Journal of Medicine in 2021, found that adults taking weekly semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% in the placebo group, when combined with diet and exercise counselling. The SURMOUNT-1 trial, published in the same journal in 2022, found that tirzepatide produced weight reductions of between 16.0% and 22.5% depending on dose, over 72 weeks. These figures come from controlled trial populations under close medical supervision, and individual results vary considerably in everyday clinical practice. They are not a guaranteed outcome of treatment at any particular clinic, and actual results depend heavily on dose, duration, adherence, and each patient’s underlying biology.
It is also worth understanding that GLP-1 injections are generally intended to be used together with, not instead of, changes to diet, physical activity, and behaviour. Doctors in Singapore typically consider a GLP-1 injection as one component of a broader weight management plan rather than a substitute for it.
Who Is a Candidate for GLP-1 Weight Loss Injection?
Not everyone who wants to lose weight is suitable for a GLP-1 injection, and this is precisely why the decision is never made before a consultation. Doctors generally look at body mass index (BMI) together with the presence of weight-related health conditions, such as high blood pressure, type 2 diabetes, or fatty liver disease, when weighing up whether medication may be appropriate. A person with a BMI in the obese range, or in the overweight range with an associated health condition, is more likely to be considered, but this still depends on a fuller clinical picture rather than the number alone.
Equally important is distinguishing between someone whose weight gain is primarily lifestyle-driven and someone with an underlying metabolic or hormonal contributor. A patient who has consistently maintained a reasonable diet and activity level but still struggles to lose weight may warrant investigation for conditions like insulin resistance, PCOS, or thyroid dysfunction before medication is even discussed. In some cases, treating the underlying condition changes the weight trajectory on its own. This is why a GP-supervised assessment, rather than self-directed use of any medication, is the appropriate starting point.
What Are the Side Effects and Risks of GLP-1 Injection for Weight Loss?
Like all prescription medicines, GLP-1 injections carry potential side effects that a doctor will discuss before starting treatment. The most common are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly when treatment is first started or the dose is increased. These effects often settle over time as the body adjusts, and doctors typically increase the dose gradually to reduce this risk.
Less common but more serious risks include pancreatitis and gallbladder problems, which is why doctors screen for relevant medical history before prescribing. Singapore’s HSA has also been monitoring, since September 2023, a potential association between GLP-1 medicines and suicidal thoughts or self-harm, following reports reviewed internationally by regulators including the European Medicines Agency and the UK’s Medicines and Healthcare products Regulatory Agency. HSA has stated that no confirmed local cases have been reported to date, but has advised healthcare professionals to exercise caution and continues to monitor the evidence. Patients should raise any changes in mood or mental wellbeing with their doctor promptly while on treatment.
Seek Medical Attention Promptly If You Experience:
- Severe or persistent abdominal pain, especially radiating to the back
- Yellowing of the skin or eyes, or pain in the upper right abdomen
- Persistent vomiting leading to signs of dehydration
- New or worsening low mood, hopelessness, or thoughts of self-harm
- Signs of a severe allergic reaction, such as facial swelling or difficulty breathing
- Unexplained, rapid weight loss without corresponding treatment
How Is Suitability for GLP-1 Injection Assessed?
Diagnosis begins with a detailed history covering weight trajectory, eating patterns, physical activity, sleep, stress, medication use, and family history of obesity or metabolic disease. A physical examination typically includes BMI calculation and waist circumference measurement, since central fat distribution carries specific health risks. Blood tests are commonly used to screen for underlying contributors such as fasting glucose or HbA1c, lipid profile, liver function, and thyroid function, and additional hormonal tests may be ordered where a condition like PCOS is suspected.
This assessment process serves two purposes. It rules out or identifies medical conditions that are driving weight gain independently of lifestyle, and it helps the doctor decide whether a patient’s overall health profile makes a GLP-1 injection, another form of treatment, or a purely lifestyle-based approach the more appropriate next step. No responsible clinic prescribes this class of medicine without first completing this kind of evaluation. Clinics such as DR+ Medical & Paincare are among the GP clinics in Singapore offering this kind of structured, GP-supervised assessment, where a GLP-1 weight loss injection is considered only after this evaluation is complete and only where lifestyle measures alone have not been effective, rather than as a starting point.
A Doctor’s Perspective
In clinical practice, two very different patients often ask about “the weight loss injection,” and telling them apart is the real work of the consultation. The first is someone whose weight has crept up gradually through predictable patterns, such as long work hours, convenient but calorie-dense food, and little time for exercise. This patient usually responds well to structured lifestyle coaching and behavioural changes, and starting with medication in this scenario risks masking the actual problem rather than solving it.
The second is someone who has genuinely tried, often for years, and still cannot shift their weight in the way their effort would suggest. In this group, a hormonal or metabolic driver is far more likely, and screening bloodwork sometimes reveals a treatable condition, such as subclinical hypothyroidism or marked insulin resistance, that changes the entire management plan. It is this second group where a GLP-1 injection is more likely to be clinically relevant, and even then, only once other contributors have been addressed or ruled out.
The pattern I would flag to patients considering GLP-1 medication, particularly those tempted to source it online or overseas without a Singapore-based assessment, is this: skipping diagnosis does not just risk an ineffective treatment, it risks missing an underlying condition that a proper work-up would have caught, and it removes the medical monitoring that catches side effects early. Early, structured assessment is what makes this treatment option safe to consider at all.
Managing Your Weight Day-to-Day: Practical Tips
Small, consistent habits tend to matter more than dramatic short-term changes. Eating regular, balanced meals rather than skipping meals and overcompensating later can help stabilise appetite and energy levels throughout the day. Building in at least some regular physical activity, even brief daily walks, supports metabolic health independently of weight change. Prioritising sleep is often overlooked, yet poor sleep is linked to increased appetite and cravings for high-calorie food. Managing stress through sustainable means, rather than through food, can also reduce a common driver of weight gain in Singapore’s high-pressure work environment. These are supportive measures, not substitutes for a proper diagnosis.
When Should You See a Doctor About Weight Loss in Singapore?
It is reasonable to see a doctor about your weight if you have tried sustained lifestyle changes without meaningful progress, if you have a BMI in the overweight or obese range together with a related health condition such as high blood pressure or diabetes, or if you simply want a clearer, medically informed understanding of your options before deciding on a path forward. No referral is needed to consult a GP about weight management in Singapore, and a consultation at a weight management clinic in Singapore is a reasonable first step to determine, through proper assessment, whether a GLP-1 injection, another medical approach, or lifestyle support alone is right for your situation.
Speak to a doctor to find out if a GLP-1 injection or another treatment approach may be suitable for you following a proper assessment.
Conclusion
GLP-1 injections represent a genuine advance in the medical management of weight, but they are not a shortcut, and they are not right for everyone. Their value lies in how precisely they are matched to the right patient, at the right point within the broader medical weight management options in Singapore, following proper assessment of what is actually driving that individual’s weight gain. If you are considering a GLP-1 injection for weight loss, the most useful first step is not the medication itself but a consultation that determines whether it, or something else entirely, is the right fit for you.
Book a consultation with our DR+ team to discuss your weight management options and find out what a proper diagnosis might reveal.
Frequently Asked Questions
Is GLP-1 the same as Ozempic or Wegovy?
GLP-1 receptor agonist is the technical name for this class of prescription medicines, often shortened to GLP-1 medicine. It is not a single product. Several different branded medicines within this drug class exist in Singapore for either diabetes management or weight management, and they are not interchangeable or identical in dosing and approved use. All are prescription-only medicines that require a doctor’s assessment before they can be prescribed.
Can I get a GLP-1 prescription without seeing a doctor in person?
No. GLP-1 medicines are prescription-only in Singapore, and by law they cannot be sold, advertised, or offered without a proper medical consultation and diagnosis. Any pathway that skips clinical assessment, including certain online or overseas sources, removes important safety checks such as medical history screening and side effect monitoring.
What happens if I stop taking a GLP-1 medication?
Weight regain after stopping is common if the underlying drivers of weight gain, and the lifestyle changes needed to sustain weight loss, were not addressed alongside treatment. This is one reason doctors treat GLP-1 therapy as part of an ongoing, monitored plan rather than a short course with a fixed endpoint. Speak to your doctor before making any changes to your treatment.
Are there non-medication options for weight loss in Singapore?
Yes. Structured dietary changes, physical activity plans, and behavioural coaching are the foundation of most weight management plans and are often effective on their own, particularly where weight gain is primarily lifestyle-driven rather than linked to an underlying metabolic condition. A doctor can help determine which approach, or combination of approaches, suits your situation.
How is a GLP-1 weight loss consultation done at DR+?
At DR+, a doctor will take a detailed history, assess BMI and waist circumference, and where indicated, order blood tests to screen for underlying conditions such as insulin resistance or thyroid dysfunction before discussing any treatment options. GLP-1 therapy, if considered relevant, is discussed only after this assessment is complete, alongside lifestyle and other treatment options.
About DR+ Medical & Paincare
DR+ Medical & Paincare is a primary care GP clinic brand with 12 locations across Singapore’s heartland estates. DR+ clinics provide general practice services, chronic disease management, and GP-supervised weight management assessments, alongside a focus on pain management. Walk-ins are welcome at all clinics during operating hours.
Medical Disclaimer
This article is intended for general informational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for diagnosis and treatment tailored to your individual condition.